Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (201-210 of 299) with videos related to

Pageof 30
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2021
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
JCI Insight|May 22, 2024
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemiaAudrey L Smith, Sydney A Skupa, Alexandria P Eiken, et al.
Blood|January 29, 2011
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma ProjectDennis D Weisenburger, Kerry J Savage, Nancy Lee Harris, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Cancer|September 25, 2014
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studyJorge J Castillo, Mark Bower, Jérémy Brühlmann, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Pageof 30

Showing results (201-210 of 299) with videos related to

Sort By:
Pageof 30
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2021
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
JCI Insight|May 22, 2024
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemiaAudrey L Smith, Sydney A Skupa, Alexandria P Eiken, et al.
Blood|January 29, 2011
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma ProjectDennis D Weisenburger, Kerry J Savage, Nancy Lee Harris, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Cancer|September 25, 2014
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studyJorge J Castillo, Mark Bower, Jérémy Brühlmann, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Pageof 30